Suchergebnisse - "Gelber, R D"

PubPharm (361)

31

Prognostic and predictive role of ESR1 status for postmenopausal patients with endocrine-responsive early breast cancer in the Danish cohort of the BIG 1-98 trial

enthalten in: Annals of oncology : official journal of the European Society for Medical Oncology | 2012

von Ejlertsen, B. | Aldridge, J. | Nielsen, K. | +10

32

Subjective cognitive complaints one year after ceasing adjuvant endocrine treatment for early-stage breast cancer

enthalten in: British journal of cancer | 2012

von Ribi, K. | Aldridge, J. | Phillips, K. | +112

33

Subjective cognitive complaints one year after ceasing adjuvant endocrine treatment for early-stage breast cancer

enthalten in: The British journal of cancer | 2012

von Ribi, K. | Aldridge, J. | Phillips, K. | +10

34

Prognostic and predictive role of ESR1 status for postmenopausal patients with endocrine-responsive early breast cancer in the Danish cohort of the BIG 1-98 trial

enthalten in: Annals of oncology | 2012

von Ejlertsen, B. | Aldridge, J. | Nielsen, K. | +10

35

The advantage of letrozole over tamoxifen in the BIG 1-98 trial is consistent in younger postmenopausal women and in those with chemotherapy-induced menopause

enthalten in: Breast cancer research and treatment | 2012

von Chirgwin, J. | Sun, Z. | Smith, I. | +108

36

Assessment of letrozole and tamoxifen alone and in sequence for postmenopausal women with steroid hormone receptor-positive breast cancer : the BIG 1-98 randomised clinical trial at 8·1 years median follow-up

enthalten in: The Lancet. Oncology | 2011

von Regan, M. | Neven, P. | Giobbie-Hurder, A. | +114

37

Long-term results of International Breast Cancer Study Group Trial VIII : adjuvant chemotherapy plus goserelin compared with either therapy alone for premenopausal patients with node-negative breast cancer

enthalten in: Annals of oncology : official journal of the European Society for Medical Oncology | 2011

von Karlsson, P. | Sun, Z. | Braun, D. | +14

38

Which patients benefit most from adjuvant aromatase inhibitors? Results using a composite measure of prognostic risk in the BIG 1-98 randomized trial

enthalten in: Annals of oncology : official journal of the European Society for Medical Oncology | 2011

von Viale, G. | Regan, M. | Dell'Orto, P. | +17

39

Which patients benefit most from adjuvant aromatase inhibitors? Results using a composite measure of prognostic risk in the BIG 1-98 randomized trial

enthalten in: Annals of oncology | 2011

von Viale, G. | Regan, M. | Dell'Orto, P. | +17

40

Long-term results of International Breast Cancer Study Group Trial VIII: adjuvant chemotherapy plus goserelin compared with either therapy alone for premenopausal patients with node-negative breast cancer

enthalten in: Annals of oncology | 2011

von Karlsson, P. | Sun, Z. | Braun, D. | +14